MRK - Merck & Co., Inc.
Close
99.52
-0.020 -0.020%
Share volume: 74,543
Last Updated: Thu 26 Dec 2024 08:30:03 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$99.54
-0.02
-0.02%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-05 | 2022-11-03 | 2023-02-24 | 2023-05-05 | 2023-08-07 | 2023-11-03 | 2024-02-26 | 2024-05-03 | |
| Assets | |||||||||
| Total Assets | 107.095 B | 107.081 B | 109.160 B | 107.796 B | 104.469 B | 106.727 B | 106.675 B | 105.849 B | |
| Current Assets | 32.116 B | 33.561 B | 35.722 B | 33.402 B | 29.977 B | 31.954 B | 32.168 B | 31.445 B | |
| Inventories | 5.535 B | 5.614 B | 5.911 B | 5.863 B | 5.930 B | 6.131 B | 6.358 B | 6.510 B | |
| Other Current Assets | 6.810 B | 7.217 B | 7.169 B | 6.737 B | 6.639 B | 6.656 B | 8.368 B | 7.950 B | |
| Short Term Investments | 6.810 B | 7.217 B | 7.169 B | 6.737 B | 6.639 B | 6.656 B | 8.368 B | 7.950 B | |
| Total Receivables | 9.643 B | 9.482 B | 9.450 B | 10.415 B | 11.030 B | 10.394 B | 10.349 B | 11.366 B | |
| Current Cash | 10.128 B | 11.248 B | 13.192 B | 10.387 B | 6.378 B | 8.773 B | 7.093 B | 5.619 B | |
| Total Non-current Assets | 74.979 B | 73.520 B | 73.438 B | 74.394 B | 74.492 B | 74.773 B | 74.507 B | 74.404 B | |
| Property Plant Equipment | 20.059 B | 20.424 B | 21.422 B | 21.758 B | 22.231 B | 22.526 B | 23.051 B | 23.045 B | |
| Other Assets | 10.972 B | 9.584 B | 9.528 B | 10.280 B | 10.187 B | 10.559 B | 11.996 B | 12.326 B | |
| Intangible Assets | 22.497 B | 21.368 B | 20.269 B | 19.857 B | 19.665 B | 19.199 B | 18.011 B | 17.572 B | |
| Goodwill | 21.213 B | 21.160 B | 21.204 B | 21.209 B | 21.195 B | 21.183 B | 21.197 B | 21.181 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 107.095 B | 107.081 B | 109.160 B | 107.796 B | 104.469 B | 106.727 B | 106.675 B | 105.849 B | |
| Total liabilities | 63.852 B | 62.623 B | 63.169 B | 60.962 B | 65.776 B | 65.481 B | 69.094 B | 65.485 B | |
| Total current liabilities | 23.168 B | 22.998 B | 24.239 B | 23.131 B | 23.394 B | 23.094 B | 25.694 B | 25.099 B | |
| Accounts Payable | 3.482 B | 3.371 B | 4.264 B | 3.680 B | 3.442 B | 3.509 B | 3.922 B | 3.514 B | |
| Other liabilities | 8.951 B | 8.660 B | 8.323 B | 8.244 B | 7.265 B | 7.343 B | 8.792 B | 8.262 B | |
| Current long term debt | 2.979 B | 1.936 B | 1.946 B | 2.672 B | 2.839 B | 887.000 M | 1.372 B | 3.077 B | |
| Long term debt | 28.684 B | 28.482 B | 28.745 B | 28.074 B | 34.072 B | 33.972 B | 33.683 B | 31.142 B | |
| Other liabilities | 8.951 B | 8.660 B | 8.323 B | 8.244 B | 7.265 B | 7.343 B | 8.792 B | 8.262 B | |
| Minority interest | 75.000 M | 66.000 M | 67.000 M | 71.000 M | 49.000 M | 54.000 M | 54.000 M | 60.000 M | |
| Total Shareholder equity | 43.243 B | 44.458 B | 45.991 B | 46.834 B | 38.693 B | 41.246 B | 37.581 B | 40.364 B | |
| Common stock | 2.531 B | 2.533 B | 2.536 B | 2.538 B | 2.539 B | 2.537 B | 2.534 B | 2.533 B | |
| Retained earnings | 58.437 B | 59.928 B | 61.081 B | 62.039 B | 54.198 B | 57.082 B | 53.895 B | 56.697 B |